Lipopolysaccharide Activating NF-kB Signaling by Regulates HTRA1 Expression in Human Retinal Pigment Epithelial Cells.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
28 Feb 2023
Historique:
received: 10 12 2022
revised: 08 01 2023
accepted: 10 01 2023
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Inflammation and elevated expression of high temperature requirement A serine peptidase 1 (HTRA1) are known high risk factors for age-related macular degeneration (AMD). However, the specific mechanism that HTRA1 causes AMD and the relationship between HTRA1 and inflammation remains unclear. We found that lipopolysaccharide (LPS) induced inflammation enhanced the expression of HTRA1, NF-κB, and p-p65 in ARPE-19 cells. Overexpression of HTRA1 up-regulated NF-κB expression, and on the other hand knockdown of HTRA1 down-regulated the expression of NF-κB. Moreover, NF-κB siRNA has no significant effect on the expression of HTRA1, suggesting HTRA1 works upstream of NF-κB. These results demonstrated that HTRA1 plays a pivotal role in inflammation, explaining possible mechanism of overexpressed HTRA1-induced AMD. Celastrol, a very common anti-inflammatory and antioxidant drug, was found to suppress inflammation by inhibiting phosphorylation of p65 protein efficaciously in RPE cells, which may be applied to the therapy of age-related macular degeneration.

Identifiants

pubmed: 36903482
pii: molecules28052236
doi: 10.3390/molecules28052236
pmc: PMC10004666
pii:
doi:

Substances chimiques

NF-kappa B 0
High-Temperature Requirement A Serine Peptidase 1 EC 3.4.21.-
Lipopolysaccharides 0
Retinal Pigments 0
HTRA1 protein, human EC 3.4.21.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 81790643, 82121003 and 82101163
Organisme : Sichuan Province Science and Technology Support Program
ID : 2021YFS0404, 2021YFS0369 and 2021YFS0388
Organisme : CAMS Innovation Fund for Medical Sciences
ID : 2019-12M-5-032
Organisme : Clinical Research Foundation of Sichuan Provincial People's Hospital
ID : 2021LY23

Références

Microvasc Res. 2017 Jan;109:45-53
pubmed: 27769693
Invest Ophthalmol Vis Sci. 2014 Sep 09;55(10):6514-23
pubmed: 25205867
Prog Retin Eye Res. 2017 Sep;60:201-218
pubmed: 28336424
J Reprod Immunol. 2004 Feb;61(1):13-30
pubmed: 15027475
Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):565-72
pubmed: 25550099
Nano Lett. 2020 Oct 14;20(10):7728-7736
pubmed: 32965124
Cell Signal. 2001 Feb;13(2):85-94
pubmed: 11257452
Science. 2006 Nov 10;314(5801):992-3
pubmed: 17053109
Int J Med Sci. 2019 Jan 1;16(1):167-179
pubmed: 30662340
Adv Exp Med Biol. 2016;928:267-289
pubmed: 27671821
Adv Clin Exp Med. 2021 Aug;30(8):859-864
pubmed: 34310874
Front Pharmacol. 2018 Feb 14;9:104
pubmed: 29491837
Eye (Lond). 2022 Aug;36(8):1631-1638
pubmed: 34326497
Annu Rev Immunol. 1996;14:649-83
pubmed: 8717528
Arthritis Rheum. 2013 Nov;65(11):2835-46
pubmed: 23982886
Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):493-497
pubmed: 28906084
J Biochem Mol Toxicol. 2019 Jul;33(7):e22329
pubmed: 30934154
Ophthalmology. 2008 Nov;115(11):1891-8
pubmed: 18718667
Genes Dis. 2021 Feb 27;9(1):62-79
pubmed: 35005108
Ageing Res Rev. 2015 Nov;24(Pt B):286-98
pubmed: 26369358
Int J Biol Sci. 2020 Sep 23;16(15):2989-3001
pubmed: 33061811
Circulation. 2002 Jun 18;105(24):2917-22
pubmed: 12070123
Circulation. 2002 Nov 12;106(20):2608-15
pubmed: 12427659

Auteurs

Shengliu Pan (S)

Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, No. 9, Section 4, Renmin South Road, Chengdu 610041, China.
University of Chinese Academy of Sciences, 380 Huaibeizhuang, Huairou District, Beijing 101408, China.

Min Liu (M)

Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, No. 4, Section 2, Jianshe North Road, Chengdu 610054, China.

Huijuan Xu (H)

Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, No. 4, Section 2, Jianshe North Road, Chengdu 610054, China.

Junlan Chuan (J)

Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, No. 4, Section 2, Jianshe North Road, Chengdu 610054, China.
Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu 610072, China.

Zhenglin Yang (Z)

University of Chinese Academy of Sciences, 380 Huaibeizhuang, Huairou District, Beijing 101408, China.
Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, No. 4, Section 2, Jianshe North Road, Chengdu 610054, China.
Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu 610072, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH